- Home
- DRUG vs FRBA Comparison
DRUG vs FRBA Comparison
Compare DRUG & FRBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- FRBA
- Stock Information
- Founded
- DRUG 2019
- FRBA 2007
- Country
- DRUG United States
- FRBA United States
- Employees
- DRUG N/A
- FRBA N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- FRBA Major Banks
- Sector
- DRUG Health Care
- FRBA Finance
- Exchange
- DRUG Nasdaq
- FRBA Nasdaq
- Market Cap
- DRUG 364.8M
- FRBA 377.6M
- IPO Year
- DRUG N/A
- FRBA N/A
- Fundamental
- Price
- DRUG $56.97
- FRBA $15.69
- Analyst Decision
- DRUG Strong Buy
- FRBA Strong Buy
- Analyst Count
- DRUG 9
- FRBA 1
- Target Price
- DRUG $81.67
- FRBA $19.00
- AVG Volume (30 Days)
- DRUG 190.6K
- FRBA 42.4K
- Earning Date
- DRUG 12-30-2025
- FRBA 10-22-2025
- Dividend Yield
- DRUG N/A
- FRBA 1.53%
- EPS Growth
- DRUG N/A
- FRBA 3.77
- EPS
- DRUG N/A
- FRBA 1.65
- Revenue
- DRUG N/A
- FRBA $135,175,000.00
- Revenue This Year
- DRUG N/A
- FRBA $15.53
- Revenue Next Year
- DRUG N/A
- FRBA $5.97
- P/E Ratio
- DRUG N/A
- FRBA $9.51
- Revenue Growth
- DRUG N/A
- FRBA 9.51
- 52 Week Low
- DRUG $23.18
- FRBA $12.74
- 52 Week High
- DRUG $70.23
- FRBA $17.40
- Technical
- Relative Strength Index (RSI)
- DRUG 49.89
- FRBA 49.05
- Support Level
- DRUG $55.01
- FRBA $15.46
- Resistance Level
- DRUG $61.81
- FRBA $16.00
- Average True Range (ATR)
- DRUG 3.80
- FRBA 0.33
- MACD
- DRUG -0.06
- FRBA 0.02
- Stochastic Oscillator
- DRUG 61.06
- FRBA 50.00
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About FRBA First Bank
First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of businesses. Its services are Business Banking; Personal banking; Digital Banking; and Lending.